SCHEMBL9316158

SCHEMBL9316158

CC(=O)C(=Cc1ccco1)C(C)=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.63
TDP1 Q9NUW8 5/20 0.63
POLB P06746 4/20 0.63
L3MBTL1 Q9Y468 3/20 0.63
KDM4E B2RXH2 1/20 0.63
KMT2A Q03164 4/20 0.59
MEN1 O00255 3/20 0.59
TSHR P16473 1/20 0.51
CYP2C19 P33261 1/20 0.51
RECQL P46063 1/20 0.49
MASP2 O00187 1/20 0.49
F2 P00734 1/20 0.49
HCAR2 Q8TDS4 1/20 0.48
ALDH1A1 P00352 4/20 0.48
PKM P14618 1/20 0.46
HTT P42858 1/20 0.46
GAA P10253 1/20 0.45
GLO1 Q04760 1/20 0.45
GLA P06280 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27465110 0.91 MAPT (0.71) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL9401911 0.86 MAPT (0.61) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL20176812 0.86 MAPT (0.61) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL9401906 0.86 MAPT (0.61) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL12358254 0.84 MAPT (0.58) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL11690331 0.82 TDP1 (0.63) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL20176814 0.82 TDP1 (0.63) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL10377521 0.82 TDP1 (0.63) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL3196199 0.82 MAPT (0.70) MAPTTDP1POLBL3MBTL1KDM4E
SCHEMBL4729615 0.80 MAPT (0.80) MAPTTDP1POLBL3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180140525-A1 AGENT FOR STABILIZING KERATIN FIBERS WITH 5-RING HETEROCYCLES HENKEL AG & CO. KGAA (DE) 2018-05-24 US claimed
EP-0357403-B1 Substituted beta-diketones ORION YHTYMAE OY (FI) 1994-12-14 EP claimed
US-5288750-A Antiulcer agents for gastrointestinal disorders ORION-YHTYMA OY (FI) 1994-02-22 US claimed
WO-1990002724-A1 SUBSTITUTED β-DIKETONES Orion-Yhtymä Oy (FI) 1990-03-22 WO claimed
EP-0357403-A2 Substituted beta-diketones ORION-YHTYMÀ„ OY (FI) 1990-03-07 EP claimed
EP-4634194-A1 SUBSTITUTED DIHYDROPYRROLO [3, 4-D] PYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS Karuna Therapeutics, Inc. (US) 2025-10-22 EP disclosed
WO-2024130068-A1 SUBSTITUTED DIHYDROPYRROLO [3, 4-D] PYRIMIDINE COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS Karuna Therapeutics, Inc. (US) 2024-06-20 WO disclosed
WO-2022254168-A1 NOVEL MOLECULES DERIVED FROM FURAN ACRYLATES AND 5-HYDROXYMETHYL FURAN ACRYLATES, HAVING UV-B FILTERING PROPERTIES INSTITUT DES SCIENCES ET INDUSTRIES DU VIVANT ET DE L'ENVIRONNEMENT - AGROPARISTECH (FR) 2022-12-08 WO disclosed
US-10561594-B2 Agent for stabilizing keratin fibers with 5-ring heterocycles HENKEL AG & CO. KGAA (DE) 2020-02-18 US disclosed
US-10561594-B2 Agent for stabilizing keratin fibers with 5-ring heterocycles HENKEL AG & CO. KGAA (DE) 2020-02-18 US disclosed
US-20180140525-A1 AGENT FOR STABILIZING KERATIN FIBERS WITH 5-RING HETEROCYCLES HENKEL AG & CO. KGAA (DE) 2018-05-24 US disclosed
US-20180140525-A1 AGENT FOR STABILIZING KERATIN FIBERS WITH 5-RING HETEROCYCLES HENKEL AG & CO. KGAA (DE) 2018-05-24 US disclosed
US-20180140525-A1 AGENT FOR STABILIZING KERATIN FIBERS WITH 5-RING HETEROCYCLES HENKEL AG & CO. KGAA (DE) 2018-05-24 US disclosed
EP-0357403-B1 Substituted beta-diketones ORION YHTYMAE OY (FI) 1994-12-14 EP disclosed
US-5288750-A Antiulcer agents for gastrointestinal disorders ORION-YHTYMA OY (FI) 1994-02-22 US disclosed
WO-1990002724-A1 SUBSTITUTED β-DIKETONES Orion-Yhtymä Oy (FI) 1990-03-22 WO disclosed
EP-0357403-A2 Substituted beta-diketones ORION-YHTYMÀ„ OY (FI) 1990-03-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180140525-A1 AGENT FOR STABILIZING KERATIN FIBERS WITH 5-RING HETEROCYCLES KRT18, NDUFS5, NDUFA5 MAPT 1624/4885TDP1 4143/4885POLB 1895/4885
US-10561594-B2 Agent for stabilizing keratin fibers with 5-ring heterocycles KRT18, NDUFS5, NDUFA5 MAPT 1624/4885TDP1 4143/4885POLB 1895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.